Tampilkan postingan dengan label JAMA. Tampilkan semua postingan
Tampilkan postingan dengan label JAMA. Tampilkan semua postingan

Selasa, 13 Juni 2017

Tiered networks save $; Teaching hospitals can save your life

Today's Managing Health Care Costs Number is 1.5%

Exchange plans have gravitated to narrow networks - and many have been encouraged that narrow networks allow higher value while being an important element of leverage with provider systems that have excellent reputations, high market leverage and command premium pricing.  Most of these high-leverage systems are anchored by academic medical centers (AMCs).  AMCs have higher costs than non-teaching hospitals because:

  • They do teaching - which increases costs as trainees order extra tests or are less efficient
  • They offer highly specialized services which have low volume
  • They take care of the sickest of the sick - and even risk adjustment probably doesn't fully reflect the real resource costs of the care they provide.

Nonetheless, it's been hard to show any correlation between this higher cost and better quality or better outcomes -and narrow networks that restrict access to the highest priced systems have proliferated, and have seemed like a good idea.

Employer plans have followed - narrow networks are frankly much more attractive than additional cost shifting to members who already face substantially more out of pocket spending than they did a few years ago.

The Commonwealth Fund showed that in Massachusetts tiered networks were associated with 5% lower costs - with no apparent loss of quality.  In Massachusetts, though, academic medical centers deliver an outsized portion of total care, and few narrow networks exclude all major teaching hospitals.

Lower metallic level plans across the country are increasingly offering no access to AMCs.  This could be a challenge for people who have severe illnesses where AMCs are required.  Presumably these plan do pay for AMC care for patients who need liver transplants or the most specialized of care -- but patients and their physicians need to jump through difficult hoops that are a special challenge to patients and their families confronting catastrophic illness.

JAMApublished research late last month that represents a challenge to narrow networks.   Researchers reviewed over  21 million Medicare admissions from 2012-2014 to major teaching hospitals (6%), minor teaching hospitals (20%), and nonteaching hospitals (74%).  They found:

Unadjusted 30-day mortality was 8.1% at major teaching hospitals, 9.2% at minor teaching hospitals, and 9.6% at nonteaching hospitals, with a 1.5% (95% CI, 1.3%-1.7%; P<.001) mortality difference between major teaching hospitals and nonteaching hospitals.

The difference persisted after risk adjustment - and was true regardless of the size of the hospital.  (Austin Frakt, one of the researchers, summarized this in the NYTimes Upshot).

Ouch.  This research looks solid.  The sample size is huge (100% of the Medicare database).   The mortality difference isn't from more aggressive diagnosis coding - and the differences are statistically significant in 13 of 15 top DRGs and 5 of 6 surgical categories.  

This is Medicare data - the difference might not be applicable to the population under 65.  Differences among hospitals within each category might still be more important than the difference between teaching hospitals and nonteaching hospitals.  But I think this research poses a serious challenge to the effort, which I've vigorously supported, to move "community" medical care away from the major teaching hospitals.

I believe that adult inpatient care will eventually follow pediatric inpatient care.  Very little inpatient pediatric care is done in non-teaching hospitals at this point.  If kids are sick enough to be in the hospital they are in a teaching hospital - otherwise they are cared for at home.  Many of the conditions that required multiple day hospitalizations when I was in training are now treated on an ambulatory basis.  That trend will continue.

But in the meantime, these researchers have shown us a caution flag in the effort to move inpatient care away from the most expensive inpatient providers.  This will make efforts to control unit prices even more important.




Senin, 24 April 2017

Health care crowds out other government spending


Today’s Managing Health Care Costs Number is $937 billion



The National Academy of Medicine published a commentary about the future of health care policy priorities in JAMA two weeks ago.  They exhort us to pay for value, empower people, activate communities and connect care – and to measure what matters, modernize skills, accelerate real-world evidence, and advance science.  All of these priorities make sense –and are especially important in light of Saturday’s March(es) for Science.

What caught my eye more than these important priorities, though, was statistics on how health care is essentially gobbling up government spending.   In 1974, one in $20 spent by the government was on health care.   In 2015 it was $1 in $4!

That’s good for employment, and it’s good for innovation in health care.  We live longer and better lives in 2017 than we did in 1974.  

But there are consequences.  The Environmental Protection Agency budget was $7.9 billion in 2000 – and was $8.1 billion in 2016.  But the paltry increase masks a huge decline in the inflation adjusted budget.  The inflation adjusted budget in 2000 would have been $10.9 billion – so the 2016 budget was a 25% decline.  The EPA employed over 18,000 in 1998; this had declined to under 15,400 in 2016 – a 15% drop.    All of this is before the almost 1/3 cut in the EPA budget proposed by the Trump Administration. 

A healthy environment leads to lower rates of disease and healthier Americans – and is usually more cost-effective (or even cost-saving) than investments in medical care.  For instance, the Clean Air Act has a cost:benefit ratio of beween 4:1 and 10:1.  We need to control medical care costs to leave room in the federal budget for other important initiatives.








Jumat, 21 April 2017

 Could we have a death panel for TrumpCare?

Could we have a death panel for TrumpCare?


Today’s Managing Health Care Costs Number is 217


Dylan Scott of Vox calls this Vampire TrumpCare – because attempts to revive the reviled American Health Care Act continue to proliferate – and the bad ideas embodied in this bill just can’t seem to be killed.

1)      The Freedom Caucus of hard-line right-wing Republicans and the Tuesday Group of self-styled moderate Republicans have been debating options to allow states to opt out of the insurance reforms of the ACA as long as they have high risk plans where disadvantaged sick people can seek refuge.   But these high risk plans are always under-funded – so many will be unable to afford the premiums.   Bad idea.

2)     Ted Cruz inveighs against the unaffordable mandates and essential benefits.   But the most controversial – free contraception – actually lowers the cost of health care.  And do we really want health plans that don’t cover maternity care, or mental health. Yup – I’m a guy in my 50s and I won’t personally be using a maternity benefit again.   But I don’t want young moms and families bankrupted by the cost of delivering a baby!  We already have the least friendly environment for young families (no mandatory maternity and paternity leave, for instance).   Do we want to make this worse?  Julie Rovner has a nice summary today in Kaiser Health News showing that the cost of these mandatory benefits is not what’s breaking the bank. Rovner also points out that doing away with standardization of insurance will make it impossible to have risk sharing for high cost members across plans.

3)      States should have choice.    Sounds good in theory – and I don’t want to have Oklahoma deciding health care policy in Massachusetts.  The New York Times has a review of how two states with Republican governors, New Mexico and Oklahoma, had vastly different approaches to Medicaid expansion and exchanges.  In New Mexico the uninsured rate plummeted, there is brisk competition of insurers on the exchanges, and premium increases have been modest.  In Oklahoma – Obamacare is a disaster.  The Supreme Court designed a great natural experiment about what happens when states have the ability to decide not to implement federal health care policy.  Just look at the disparity among states in Medicaid expansion to see how well that worked!
 
4)      All Republican repeal plans erase the individual mandate.  Fine – no one wants to be told what to do.  But getting the healthy to purchase insurance is critical to having sustainable insurance markets.  Insurers won’t sell insurance at reasonable prices if people only purchase that insurance when they are already sick, much as you can’t purchase home insurance when  your house is burning down.  Many dislike the individual mandate philosophically – but have offered no great alternative. Regina Herzlinger, a conservative, pro-market Harvard Business School professor, has a review in JAMA of how Switzerland, Germany and Singapore achieve universal coverage without turning to a single payer . The answer in two words: Individual Mandate. The answer in a paragraph:

Switzerland, Singapore, and Germany have achieved universal coverage and made insurance affordable even for their citizens with highest health care costs by instituting an individual mandate. One major difference, however, is that unlik   e the ACA, the mandates instituted by these countries are reinforced with effective penalties for nonparticipation, thus ensuring that lower-cost enrollees—generally healthier individuals—balance out the costs of the others who require more medical resources.

Trump has set another deadline for voting on TrumpCare: Wednesday 4/27.   The bill continues to be a collection of bad ideas that have already been disproven in the market.   Sarah Kliff points out that the barriers to passing this poorly designed legislation are Yuge.  They need 217 votes – let’s hope they continue to fall short. 

Selasa, 03 Januari 2017

JAMA follows the money


Today's Managing Health Care Costs Number is $3.2 trillion
Medical Spending for Women by Age 

Source for all graphics
Happy 2017 - and I'm back blogging after a week of rest and contemplation.  I'm sure we're all in for an interesting year of health care policy -and I'll be blogging on Republican efforts to repeal the Affordable Care Act over the coming days too.

JAMA published a blockbuster description of where medical dollars are spent in the United States- using data from various federal surveys, Truven's MarketScan database, and Medicare claims.   The analysis divides cost up by age/gender cell as well as by disease category.   It does not specify what payer is responsible for costs, but does split out those over 64 (largely covered by Medicare) and those under 20 (usually inexpensive -and often covered by Medicaid) - so you can get a sense from this of employer spending as well.  The researchers also reviewed where public health dollars are spent.  No surprise - there is a low correlation with where health care treatment dollars are spent.

General findings.
  • Chronic diseases rule.   Ten of the 14 top conditions are chronic conditions - led by cardiovascular disease, diabetes, other noncommunicable disease, mental health disorders and musculoskeletal disorders.  Taken together, these represent about a trillion dollars in spending.
  • Women have higher medical costs than men (even excluding pregnancy related costs
  • With the exception of (sick) newborns, we spend progressively more money on Americans as they get older. 
  • There are a few conditions, like hypertension, where generic drugs have led to a dramatic decrease in pharmaceutical costs for treatment.  There are others, like diabetes, where the drug spending continues to escalate.

Ezekiel Emanuel penned an accompanying editorial .   

In 2015, the United States spent roughly $3.2 trillion on health care. That is a staggering, almost unimaginable amount. Indeed, this level of spending makes the US health care system the fifth largest economy in the world, behind only the US, Chinese, Japanese, and German national economies.

Emanuel notes the large spending on mental health care (despite evidence that treatment is now terrible), the serious cost of pain, and the mismatch of public health spending and medical costs. He notes that almost 22% of dollars spent on those over 65 are spent at skilled nursing facilities - again without evidence that the care is of high quality, and that expenditures for drugs keep on going up.

The effort to collate this data is enormous (there are 26 coauthors of this article) - but knowing where we are spending dollars helps us know where to look for potential savings.  The costs of noncommunicable diseases also loom large -and societal efforts to decrease risk factors are bound to create more value than treatment of existing disease.



Note how drug spending has increased substantially for diabetes -which is dominated by brand name and single source medications, but it has diminished for hypertension, where most drug classes are available as generics.  Source 

Senin, 14 November 2016

Medicare to start cardiac bundles


Today’s Managing Health Care Costs Number is $200 billion


Interquartile cost variation, 2005 

Source: Health Services Research, (2010)

A post with (almost) no reference to the 2016 Presidential election follows.

This week’s JAMA has a review of the Center for Medicare and Medicaid Services plan to move to 90 day bundled payment for heart attacks and bypass surgery.  Medicare pays $200 billion annually for this care.

The plan will go into effect in July, 2017 – and budgets will initially be determined by historical hospital costs.  However, in 2020 the budgets will instead by based on regional expenses – which could mean high-cost hospitals will face a substantial pay cut.

The program offers a single payment to the hospital, which would pay affiliated physicians.  Readmissions (in the first 90 days) would be included –and all results would be risk adjusted.   Hospitals would only be eligible for bonus payments if they met quality standards.

Virtually all of the projected cost savings from this program, which would roll out to 98 randomly selected metropolitan areas, would come in the final years when hospitals will have a larger risk corridor and be judged based on regional rather than hospital-specific results.

There’s a lot of promise here

1)     Cardiac care and cardiac surgery is well standardized – there is not massive disagreement about what care is “best.”
2)     A previous Medicare bundled payment program for cardiac surgery was highly successful.  This was the only payment reform program that the CBO judged a success, although it has never been replicated or expanded
3)     There is a huge amount of variation between the higher and the lower cost facilities, which is not definitively related to quality.
4)     The bundles are hospital –centric, as opposed to many other episodes where a substantial portion of the cost is ambulatory
5)     The program will be implemented in randomly chosen areas – allowing for high quality studies to determine efficacy
6)     There is substantial volume and money here – so if value of care is improved many patients will benefit and much money can be saved.

But there will be objections.    Physicians who are not employed by hospitals are worried about hospitals controlling professional reimbursements.    Academic medical centers with high historic costs will be justifiably worried, and will lobby for a longer phase in period for regional budgets.   Or they will argue against the program altogether.  This payment reform is related to MACRA(The Medicare Access and CHIP Reauthorization Act of 2015) rather than to the Affordable Care Act. 

(OK – so this is not totally without a glancing reference to the elections).